Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittman

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Science Advances|March 22, 2024
<i>SF3B1</i> mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemiaCéline Moison, Deanne Gracias, Julie Schmitt, et al.
JAMA Network Open|May 1, 2026
Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract InfectionsKristin N Ray, Samuel R Wittman, Mary Kate Kelly, et al.
Carcinogenesis|February 17, 2026
A watercress drink increases detoxification of common environmental carcinogens such as acrolein and benzene: Results of a randomized clinical trialStephen S Hecht, Steven G Carmella, Saonli Basu, et al.
JAMA Network Open|February 6, 2026
Peer Navigator Intervention and Opioid-Related Adverse Events for Emergency Department Patients: A Randomized Clinical TrialKelly M Doran, Alice E Welch, Kelsey L Kepler, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHAZhijian Zhao, David D Wisnoski, Julie A O'Brien, et al.
Physiological Reports|May 31, 2018
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significanceHanan M Garalla, Nantaporn Lertkowit, Laszlo Tiszlavicz, et al.
Molecular Cancer Therapeutics|December 10, 2009
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IRJoan M Carboni, Mark Wittman, Zheng Yang, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activityUpender Velaparthi, Mark Wittman, Peiying Liu, et al.
Bioorganic & Medicinal Chemistry|December 6, 2011
Biochemical and transcriptional profiling to triage additional activities in a series of IGF-1R/IR inhibitorsPetra Ross-Macdonald, Heshani de Silva, Vishal Patel, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Science Advances|March 22, 2024
<i>SF3B1</i> mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemiaCéline Moison, Deanne Gracias, Julie Schmitt, et al.
JAMA Network Open|May 1, 2026
Primary Care Telemedicine vs In-Person Antibiotic Prescribing for Pediatric Respiratory Tract InfectionsKristin N Ray, Samuel R Wittman, Mary Kate Kelly, et al.
Carcinogenesis|February 17, 2026
A watercress drink increases detoxification of common environmental carcinogens such as acrolein and benzene: Results of a randomized clinical trialStephen S Hecht, Steven G Carmella, Saonli Basu, et al.
JAMA Network Open|February 6, 2026
Peer Navigator Intervention and Opioid-Related Adverse Events for Emergency Department Patients: A Randomized Clinical TrialKelly M Doran, Alice E Welch, Kelsey L Kepler, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2007
Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHAZhijian Zhao, David D Wisnoski, Julie A O'Brien, et al.
Physiological Reports|May 31, 2018
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significanceHanan M Garalla, Nantaporn Lertkowit, Laszlo Tiszlavicz, et al.
Molecular Cancer Therapeutics|December 10, 2009
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IRJoan M Carboni, Mark Wittman, Zheng Yang, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activityUpender Velaparthi, Mark Wittman, Peiying Liu, et al.
Bioorganic & Medicinal Chemistry|December 6, 2011
Biochemical and transcriptional profiling to triage additional activities in a series of IGF-1R/IR inhibitorsPetra Ross-Macdonald, Heshani de Silva, Vishal Patel, et al.
Pageof 29